{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:10:26Z","timestamp":1783923026311,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023A1515011863"],"award-info":[{"award-number":["2023A1515011863"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2025ZD01904300"],"award-info":[{"award-number":["2025ZD01904300"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018536","name":"National Mega Project on Major Infectious Disease Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018536","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072276"],"award-info":[{"award-number":["82072276"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bcp.2026.118061","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T15:14:43Z","timestamp":1778771683000},"page":"118061","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Halofuginone suppresses HSV-2 through direct viral inhibition and host ProRS inhibition"],"prefix":"10.1016","volume":"251","author":[{"given":"Zhizhi","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuening","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suiyi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9605","key":"10.1016\/j.bcp.2026.118061_b0005","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(07)61908-4","article-title":"Genital herpes","volume":"370","author":"Gupta","year":"2007","journal-title":"Lancet"},{"issue":"19 Suppl 1","key":"10.1016\/j.bcp.2026.118061_b0010","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.vaccine.2024.01.044","article-title":"Vaccine value profile for herpes simplex virus","volume":"42","author":"Johnston","year":"2024","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.bcp.2026.118061_b0015","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/sextrans-2024-056307","article-title":"Estimated global and regional incidence and prevalence of herpes simplex virus infections and genital ulcer disease in 2020: mathematical modelling analyses","volume":"101","author":"Harfouche","year":"2025","journal-title":"Sex. Transm. Infect."},{"issue":"1","key":"10.1016\/j.bcp.2026.118061_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/v15010225","article-title":"A comprehensive overview of epidemiology, pathogenesis and the management of herpes labialis","volume":"15","author":"Gopinath","year":"2023","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.bcp.2026.118061_b0025","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1473-3099(17)30405-X","article-title":"Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis","volume":"17","author":"Looker","year":"2017","journal-title":"Lancet Infect. Dis."},{"issue":"12","key":"10.1016\/j.bcp.2026.118061_b0030","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1097\/QAD.0b013e32825a69bd","article-title":"Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes","volume":"21","author":"LeGoff","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.bcp.2026.118061_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115322","article-title":"Acyclovir resistance in herpes simplex viruses: prevalence and therapeutic alternatives","volume":"206","author":"Schalkwijk","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118061_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2018.01.003","article-title":"Thymidine kinase and protein kinase in drug-resistant herpesviruses: heads of a Lernaean Hydra","volume":"37","author":"Topalis","year":"2018","journal-title":"Drug Resist. Updat."},{"issue":"9","key":"10.1016\/j.bcp.2026.118061_b0045","article-title":"The path towards effective long-lasting tissue-targeted prime\/pull\/keep herpes simplex therapeutic vaccines","volume":"13","author":"Quadiri","year":"2025","journal-title":"Vaccines (basel)"},{"key":"10.1016\/j.bcp.2026.118061_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2025.106152","article-title":"Overview on the management of herpes simplex virus infections: current therapies and future directions","volume":"237","author":"Birkmann","year":"2025","journal-title":"Antiviral Res."},{"issue":"288","key":"10.1016\/j.bcp.2026.118061_b0055","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa3575","article-title":"The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs","volume":"7","author":"Herman","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"12","key":"10.1016\/j.bcp.2026.118061_b0060","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.ejca.2005.12.027","article-title":"Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours","volume":"42","author":"de Jonge","year":"2006","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2026.118061_b0065","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/QAI.0b013e3181fc0141","article-title":"Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma","volume":"56","author":"Koon","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"7","key":"10.1016\/j.bcp.2026.118061_b0070","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1083-8791(03)00151-4","article-title":"Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma","volume":"9","author":"Pines","year":"2003","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"17","key":"10.1016\/j.bcp.2026.118061_b0075","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1111\/bph.15442","article-title":"Halofuginone, a promising drug for treatment of pulmonary hypertension","volume":"178","author":"Jain","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118061_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.101080","article-title":"New uses of halofuginone to treat cancer","volume":"15","author":"Zuo","year":"2025","journal-title":"J. Pharm. Anal."},{"issue":"9","key":"10.1016\/j.bcp.2026.118061_b0085","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1016\/j.drudis.2022.05.020","article-title":"Prospects of halofuginone as an antiprotozoal drug scaffold","volume":"27","author":"Gill","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bcp.2026.118061_b0090","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.antiviral.2018.11.017","article-title":"A potent prolyl tRNA synthetase inhibitor antagonizes Chikungunya and Dengue viruses","volume":"161","author":"Hwang","year":"2019","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bcp.2026.118061_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173782","article-title":"T-type calcium channels blockers inhibit HSV-2 infection at the late stage of genome replication","volume":"892","author":"Ding","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118061_b0100","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41401-022-00975-7","article-title":"TRPV4 channel is involved in HSV-2 infection in human vaginal epithelial cells through triggering Ca(2+) oscillation","volume":"44","author":"Jiang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bcp.2026.118061_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114595","article-title":"A potential anti-HIV-1 compound, Q308, inhibits HSV-2 infection and replication in vitro and in vivo","volume":"162","author":"Zhang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.bcp.2026.118061_b0110","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bcp.2026.118061_b0115","article-title":"Rational design of a novel small-molecule HIV-1 inactivator targeting both gp120 and gp41 of HIV-1","volume":"11","author":"Pu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118061_b0120","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3390\/v14050861","article-title":"Montelukast Inhibits HCoV-OC43 Infection as a Viral Inactivator","author":"Chen","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.bcp.2026.118061_b0125","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.3389\/fmicb.2019.02250","article-title":"A peptide-based virus inactivator protects male mice against Zika virus-induced damage of testicular tissue","volume":"10","author":"Si","year":"2019","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118061_b0130","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/ame2.12575","article-title":"Animal models of human herpesvirus infection","volume":"8","author":"Jia","year":"2025","journal-title":"Animal Model Exp Med"},{"issue":"7","key":"10.1016\/j.bcp.2026.118061_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008795","article-title":"An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection","volume":"16","author":"Egan","year":"2020","journal-title":"PLoS Pathog."},{"issue":"44","key":"10.1016\/j.bcp.2026.118061_b0140","doi-asserted-by":"crossref","first-page":"17263","DOI":"10.1039\/C7NR05859D","article-title":"Carbosilane dendrons with fatty acids at the core as a new potential microbicide against HSV-2\/HIV-1 co-infection","volume":"9","author":"Guerrero-Beltr\u00e1n","year":"2017","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.bcp.2026.118061_b0145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12985-025-02867-8","article-title":"Small molecule UCM05 inhibits HSV-2 infection via targeting viral glycoproteins and fatty acid synthase with potentiating antiviral immunity","volume":"22","author":"Li","year":"2025","journal-title":"Virol. J."},{"issue":"10","key":"10.1016\/j.bcp.2026.118061_b0150","first-page":"1499","article-title":"X-ray diffraction analysis of glycoprotein D from herpes simplex virus type 2","volume":"27","author":"Chen","year":"2011","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"issue":"5","key":"10.1016\/j.bcp.2026.118061_b0155","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrmicro2548","article-title":"Fusing structure and function: a structural view of the herpesvirus entry machinery","volume":"9","author":"Connolly","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bcp.2026.118061_b0160","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiaf095","article-title":"Chemical targeting of prolyl-tRNA synthetase stalls ovarian development and kills malaria vectors","author":"Goswami","year":"2025","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.bcp.2026.118061_b0165","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.antiviral.2011.10.016","article-title":"Genotypic characterization of herpes simplex virus DNA polymerase UL42 processivity factor","volume":"93","author":"Burrel","year":"2012","journal-title":"Antiviral Res."},{"issue":"9","key":"10.1016\/j.bcp.2026.118061_b0170","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a013011","article-title":"Herpes simplex viruses: mechanisms of DNA replication","volume":"4","author":"Weller","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"13","key":"10.1016\/j.bcp.2026.118061_b0175","doi-asserted-by":"crossref","first-page":"7379","DOI":"10.1128\/JVI.00712-14","article-title":"Herpes simplex virus protein kinases US3 and UL13 modulate VP11\/12 phosphorylation, virion packaging, and phosphatidylinositol 3-kinase\/Akt signaling activity","volume":"88","author":"Eaton","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2026.118061_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105145","article-title":"Prophylactic treatment with BX795 blocks activation of AKT and its downstream targets to protect vaginal keratinocytes and vaginal epithelium from HSV-2 infection","volume":"194","author":"Madavaraju","year":"2021","journal-title":"Antiviral Res."},{"issue":"23","key":"10.1016\/j.bcp.2026.118061_b0185","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1101\/gad.1978310","article-title":"Constitutive mTORC1 activation by a herpesvirus Akt surrogate stimulates mRNA translation and viral replication","volume":"24","author":"Chuluunbaatar","year":"2010","journal-title":"Genes Dev."},{"issue":"6","key":"10.1016\/j.bcp.2026.118061_b0190","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1101\/gad.1185304","article-title":"Phosphorylation of eIF4E by Mnk-1 enhances HSV-1 translation and replication in quiescent cells","volume":"18","author":"Walsh","year":"2004","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.bcp.2026.118061_b0195","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-virology-100114-054839","article-title":"Modulation of the translational landscape during herpesvirus infection","volume":"2","author":"Glaunsinger","year":"2015","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.bcp.2026.118061_b0200","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.intimp.2018.09.043","article-title":"The antiviral activity of arbidol hydrochloride against herpes simplex virus type II (HSV-2) in a mouse model of vaginitis","volume":"68","author":"Du","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118061_b0205","first-page":"927","article-title":"Synergistic effect of halofuginone and dexamethasone on LPS\u2011induced acute lung injury in type II alveolar epithelial cells and a rat model","volume":"21","author":"Du","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2026.118061_b0210","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1038\/s41598-025-88258-z","article-title":"Halofuginone prevents inflammation and proliferation of high-altitude pulmonary hypertension by inhibiting the TGF-\u03b21\/Smad signaling pathway","volume":"15","author":"Wang","year":"2025","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2026.118061_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2025.106636","article-title":"From HSV-2 to HSV-1: a change in the epidemiology of genital herpes","volume":"91","author":"Andreu","year":"2025","journal-title":"J. Infect."},{"issue":"4","key":"10.1016\/j.bcp.2026.118061_b0220","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1086\/315836","article-title":"Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in african women: opportunities for intervention","volume":"182","author":"Mbopi-K\u00e9ou","year":"2000","journal-title":"J Infect Dis"},{"issue":"50","key":"10.1016\/j.bcp.2026.118061_b0225","doi-asserted-by":"crossref","first-page":"7363","DOI":"10.1016\/j.vaccine.2017.09.044","article-title":"Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development","volume":"37","author":"Schiffer","year":"2019","journal-title":"Vaccine"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226003941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226003941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:34:07Z","timestamp":1783920847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226003941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":45,"alternative-id":["S0006295226003941"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118061","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Halofuginone suppresses HSV-2 through direct viral inhibition and host ProRS inhibition","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118061"}}